genprowebdirectory
GEN Edge
News
Insights
Trends for 2020
A-Lists
Topics
Bioprocessing
Cancer
Drug Discovery
OMICs
Translational Medicine
Genome Editing
Magazine
Supplement
Resources
Posters
Videos
Webinars
eBooks
Podcasts
Events
New Products
Tutorial
Best of the Web
Best Apps
Subscribe
Create a Free Account
Get GEN Edge
Log In
Get GEN Magazine
Get GEN eNewsletters
Get the GEN Mobile App
Get GEN News from Alexa
Search
Advertising
Magazine Advertising
Website Banner Advertising
eNewsletter Advertising
Webinar Sponsorship
eBook Advertising
Email Nurture Campaigns
Ad Terms and Conditions
About GEN
Contact GEN
Create a Free Account
Get GEN Edge
Log In
GEN – Genetic Engineering and Biotechnology News
Mary Ann Liebert, Inc. Publishers
GEN Edge
Coronavirus
COVID-19 Puts Spotlight on Artificial Intelligence
Data Management
VAST Ambition When It Comes To Data Storage
Antisense
NeuBase Sets a Course for the Clinic
Bioprocessing
Cytiva Picks Up Where GE Leaves Off after $21B Deal
Coronavirus
Putting COVID-19 on the ‘Map’
News
Cardiovascular Testing
Over 200 Genetic Factors Found Linked to Heart Arrhythmias
Bioprocessing
Cytiva Teams Up with Takara Bio to Work on COVID-19 Vaccine…
Bioprocessing
Rentschler Biopharma Licenses Horizon Discovery’s CHOSOURCE Platform
OMICs
Ketogenic Diet Alters Gut Microbiome Leading to Reduced Levels of Proinflammatory…
Coronavirus
SARS-CoV-2 Prototype Vaccine Protects Macaques
Insights
All
Trends for 2020
Bioprocessing
Introducing New Bioprocessing Technologies in the Era of COVID-19
Bioprocessing
Smart AI Use Could Benefit Biopharma
Bioprocessing
Digital Ecosystem Combines Process Control, Analytics, and Plant-Level Automation
Bioprocessing
Coronavirus Vaccine Race Approaching Quality Control Hurdle
A-Lists
Coronavirus
Blinking Red: 25 Missed Pandemic Warning Signs
Coronavirus
Vanquishing the Virus: 160+ COVID-19 Drug and Vaccine Candidates in Development
Coronavirus
Catching Up to Coronavirus: Top 60 Treatments in Development
Drug Discovery
Top 15 Best-Selling Drugs of 2019
Coronavirus
How to Conquer Coronavirus: Top 35 Treatments in Development
Topics
All
Bioprocessing
Cancer
Drug Discovery
OMICs
Translational Medicine
Genome Editing
Sponsored
Saving Science by Saving Mice
Bioprocessing
Cytiva Teams Up with Takara Bio to Work on COVID-19 Vaccine…
Bioprocessing
Rentschler Biopharma Licenses Horizon Discovery’s CHOSOURCE Platform
Upcoming Webinars
Looking toward the Future of Cell & Gene Therapies
Magazine
All
Supplement
Coronavirus
Race for a Coronavirus Vaccine
Drug Discovery
Protein Modulation Helps Drug Design Get a Grip
OMICs
Proteomic Mass Spec Assesses Biomolecular Teamwork
Coronavirus
COVID-19 Drives CRISPR Diagnostics
Resources
All
Posters
Videos
Webinars
eBooks
Podcasts
Events
New Products
Tutorial
Best of the Web
Best Apps
Upcoming Webinars
Looking toward the Future of Cell & Gene Therapies
Upcoming Webinars
DNA as Medicine: Encoding Cancer Therapeutic Antibodies
GENcast
Trends in Bioprocess 4.0 and their Impact on Biomanufacturing
Upcoming Webinars
Streamlining High-Throughput Impurity Analysis in Process Development
Subscribe
Create a Free Account
Get GEN Edge
Log In
Get GEN Magazine
Get GEN eNewsletters
Get the GEN Mobile App
Get GEN News from Alexa
Home
Companies
AstraZeneca
AstraZeneca
Latest
Latest
Featured posts
Most popular
7 days popular
By review score
Random
AstraZeneca
AstraZeneca Joins U. of Oxford and Spinout to Develop COVID-19 Vaccine
AstraZeneca
Allergan Sells Zenpep, Brazikumab as Regulators Review AbbVie $63B Deal
AstraZeneca
AstraZeneca to Create $1B Fund, R&D Centers in China
AstraZeneca
AveXis to Acquire AstraZeneca Manufacturing Site in Longmont, CO
AstraZeneca
AstraZeneca, Daiichi Sankyo Launch Potentially $6.9B+ Collaboration to Develop Cancer ADC
AstraZeneca
Moderna Raises Size of its Largest-Ever Biotech IPO to $600M
AstraZeneca
AstraZeneca’s Imfinzi Fails 2nd Primary Endpoint in Phase III MYSTIC Trial
AstraZeneca
Sobi Buys Synagis U.S. Rights, Half Share of MEDI18897 U.S. Profits...
AstraZeneca
Grünenthal Acquires Partial Rights to Nexium, Vimovo from AstraZeneca for Up-to-$922M
AstraZeneca
After Second Phase III Failure, AstraZeneca Retreats from COPD Filing Plans...
AstraZeneca
AstraZeneca Weighs Expanding Fasenra to COPD after Phase III Failure
AstraZeneca
AstraZeneca, SWIBCo Launch Stem Cell Cardiovascular Therapy Collaboration
AstraZeneca
After Patient Dies, FDA Imposes Clinical Hold on Trial of Advaxis/AstraZeneca...
AstraZeneca
With $250M in Financing, AstraZeneca Spinout to Focus on Severe Autoimmune...
AstraZeneca
Bavarian Nordic Launches Study of Cancer Vaccine CV301 with AstraZeneca’s Imfinzi
Load more
Scroll Up
Please wait while you are redirected to the right page...
We use cookies to give you a better experience on genengnews.com. By continuing to use our site, you are agreeing to the use of cookies as set in our
privacy policy.
Got it!
Edit with Live CSS
/* The alert message box */ .alert { padding: 20px; background-color: #ff9800; /* Red */ color: white; margin-bottom: 15px; } /* The close button */ .closebtn { margin-left: 15px; color: white; font-weight: bold; float: right; font-size: 22px; line-height: 20px; cursor: pointer; transition: 0.3s; } /* When moving the mouse over the close button */ .closebtn:hover { color: black; } .td_module_flex_2 .entry-title { font-size: 17px; line-height: 20px; }
![New research suggest ketogenic diets may cause an increased risk of Type 2 diabetes in the early stage of the diet. [United States Air Force]](https://www.genengnews.com/wp-content/uploads/2018/08/Aug9_2018_KirtlandAirForceBase_KetogenicDiet_SalmonButterOliveOilCoconutSteak1801911782-218x150.jpg "Ketogenic Diet Alters Gut Microbiome Leading to Reduced Levels of Proinflammatory T Cells")
